Ligand Pharmaceuticals incurred a GAAP loss of $2,045 million in 6 months of 2020 against a profit of $651,918 million in the previous year. Revenues increased by 8.9% to $74,581 million compared to $68,471 million a year earlier.
Ligand Pharmaceuticals incurred a GAAP loss of $2,045 million in 6 months of 2020 against a profit of $651,918 million in the previous year. Revenues increased by 8.9% to $74,581 million compared to $68,471 million a year earlier. 
investor.ligand.com
English (US) 